These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 12442215)

  • 1. [Introduction of disease management programmes in Germany as reflected by differing interests of health insurance companies and the federal association of statutory health insurance physicians].
    Erler A
    Gesundheitswesen; 2002 Nov; 64(11):572-7. PubMed ID: 12442215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Deficiencies in the mandatory health insurance system"--possibilities and limits of medical expert assessment].
    Mayer ED; Boukamp K; Zink J; Simoes E; Schwoerer P
    Gesundheitswesen; 2000 Oct; 62(10):538-46. PubMed ID: 11103565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disease management programs from a health insurer's point of view].
    Szymkowiak C; Walkenhorst K; Straub C
    Z Arztl Fortbild Qualitatssich; 2003 Jun; 97(3):201-6. PubMed ID: 12856546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Practice guidelines in rehabilitation: infringement upon physicians' autonomy or foundation for better outcomes?].
    Brüggemann S; Korsukéwitz C
    Rehabilitation (Stuttg); 2004 Oct; 43(5):304-11. PubMed ID: 15472789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [After seven years of National Disease Management Guidelines: quo vadis?].
    Weinbrenner S; Conrad S; Weikert B; Kopp I
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(7):533-9. PubMed ID: 21095605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relevance of medical rehabilitation in disease management programmes].
    Lüngen M; Lauterbach KW
    Rehabilitation (Stuttg); 2003 Oct; 42(5):284-9. PubMed ID: 14551831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The German program for disease management guidelines. Results and perspectives].
    Ollenschläger G; Kopp I
    Med Klin (Munich); 2007 May; 102(5):383-7. PubMed ID: 17497089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of Federal Health Insurance process data as instrument for structural and quality analysis of inpatient care].
    Swart E; Robra BP; Leber WD
    Gesundheitswesen; 1997 Jan; 59(1):10-6. PubMed ID: 9138641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ENT expert assessment for federal health insurance in North Rhine. A contribution to the internal discussion of quantitative and qualitative optimization of the expert witness process].
    Lauven G; Buszello HP; Müller-Held W
    Gesundheitswesen; 1999 Apr; 61(4):179-84. PubMed ID: 10408144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations].
    Drabik A; Graf C; Büscher G; Stock S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):649-55. PubMed ID: 23200208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health Care Reform 2007 and its legal consequences for medical rehabilitation--statement from the perspective of the Federal Rehabilitation Council, BAR].
    Stähler T; Petri B
    Rehabilitation (Stuttg); 2007 Oct; 46(5):310-4. PubMed ID: 17955398
    [No Abstract]   [Full Text] [Related]  

  • 14. [Services and benefits for medical rehabilitation and integrated health care].
    Fuchs H
    Rehabilitation (Stuttg); 2004 Oct; 43(5):325-34. PubMed ID: 15472791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines in surgery: from the viewpoint of the advisory council].
    Scriba PC
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():68-71. PubMed ID: 9574099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rehabilitation from the economic viewpoint in relation to the legal social security insurance].
    Schliehe F
    Z Gerontol Geriatr; 1997 Dec; 30(6):456-68. PubMed ID: 9499488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-benefit evaluation of medical rehabilitation by social security pensions and effects of the growth and occupational rehabilitation regulation (WFG)].
    Hansmeier T; Müller-Fahrnow W; Klosterhuis H; Spyra K
    Z Gerontol Geriatr; 1997 Dec; 30(6):450-5. PubMed ID: 9499487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality management from the viewpoint of the Federal Public Health Ministry].
    Luithlen E
    Herz; 1996 Oct; 21(5):299-303. PubMed ID: 9011538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality in public health. Deficits, concepts and political quality key issues from the ministerial viewpoint].
    Ruprecht TM
    Z Arztl Fortbild Qualitatssich; 1997 Feb; 91(1):75-81. PubMed ID: 9221209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality assurance in medical care].
    Oberender P; Daumann F
    Gesundheitswesen; 1996; 58(8-9):447-53. PubMed ID: 9011260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.